Sarcopaenia in surgical populations: A review

Rachel S.M. Heard, George Ramsay, Diane R. Hildebrand* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Sarcopaenia, or decreased muscle mass, has been the subject of a large quantity of recent literature in both medical and surgical disciplines. It has been shown, as outlined below, to be of great prognostic importance, and also may be used in certain circumstances to guide treatment. The greatest volume of research into this topic is in oncological surgical populations, in whom the prevalence of sarcopaenia has been shown to be high. However it is being increasingly studied in other patient groups. Interest in using sarcopaenia as an objective and potentially modifiable marker of frailty is increasing, especially with regards to pre-operative risk stratification and amelioration. In this review we consider the current literature regarding the cause and effect of sarcopaenia, the methods by which it may be identified and the potential ways in which it may be treated, in the interest of improving outcomes for surgical patients.

Original languageEnglish
Pages (from-to)366-371
Number of pages6
JournalSurgeon
Volume15
Issue number6
Early online date3 Jul 2017
DOIs
Publication statusPublished - 1 Dec 2017

Fingerprint

Population
Muscles
Research
Therapeutics

Keywords

  • Frailty
  • Sarcopaenia
  • Surgery

ASJC Scopus subject areas

  • Surgery

Cite this

Sarcopaenia in surgical populations : A review. / Heard, Rachel S.M.; Ramsay, George; Hildebrand, Diane R. (Corresponding Author).

In: Surgeon, Vol. 15, No. 6, 01.12.2017, p. 366-371.

Research output: Contribution to journalReview article

Heard, Rachel S.M. ; Ramsay, George ; Hildebrand, Diane R. / Sarcopaenia in surgical populations : A review. In: Surgeon. 2017 ; Vol. 15, No. 6. pp. 366-371.
@article{dd666ac70df14ff19fc78859746fa9d4,
title = "Sarcopaenia in surgical populations: A review",
abstract = "Sarcopaenia, or decreased muscle mass, has been the subject of a large quantity of recent literature in both medical and surgical disciplines. It has been shown, as outlined below, to be of great prognostic importance, and also may be used in certain circumstances to guide treatment. The greatest volume of research into this topic is in oncological surgical populations, in whom the prevalence of sarcopaenia has been shown to be high. However it is being increasingly studied in other patient groups. Interest in using sarcopaenia as an objective and potentially modifiable marker of frailty is increasing, especially with regards to pre-operative risk stratification and amelioration. In this review we consider the current literature regarding the cause and effect of sarcopaenia, the methods by which it may be identified and the potential ways in which it may be treated, in the interest of improving outcomes for surgical patients.",
keywords = "Frailty, Sarcopaenia, Surgery",
author = "Heard, {Rachel S.M.} and George Ramsay and Hildebrand, {Diane R.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.surge.2017.06.001",
language = "English",
volume = "15",
pages = "366--371",
journal = "The Surgeon",
issn = "1479-666X",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Sarcopaenia in surgical populations

T2 - A review

AU - Heard, Rachel S.M.

AU - Ramsay, George

AU - Hildebrand, Diane R.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Sarcopaenia, or decreased muscle mass, has been the subject of a large quantity of recent literature in both medical and surgical disciplines. It has been shown, as outlined below, to be of great prognostic importance, and also may be used in certain circumstances to guide treatment. The greatest volume of research into this topic is in oncological surgical populations, in whom the prevalence of sarcopaenia has been shown to be high. However it is being increasingly studied in other patient groups. Interest in using sarcopaenia as an objective and potentially modifiable marker of frailty is increasing, especially with regards to pre-operative risk stratification and amelioration. In this review we consider the current literature regarding the cause and effect of sarcopaenia, the methods by which it may be identified and the potential ways in which it may be treated, in the interest of improving outcomes for surgical patients.

AB - Sarcopaenia, or decreased muscle mass, has been the subject of a large quantity of recent literature in both medical and surgical disciplines. It has been shown, as outlined below, to be of great prognostic importance, and also may be used in certain circumstances to guide treatment. The greatest volume of research into this topic is in oncological surgical populations, in whom the prevalence of sarcopaenia has been shown to be high. However it is being increasingly studied in other patient groups. Interest in using sarcopaenia as an objective and potentially modifiable marker of frailty is increasing, especially with regards to pre-operative risk stratification and amelioration. In this review we consider the current literature regarding the cause and effect of sarcopaenia, the methods by which it may be identified and the potential ways in which it may be treated, in the interest of improving outcomes for surgical patients.

KW - Frailty

KW - Sarcopaenia

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=85023743144&partnerID=8YFLogxK

U2 - 10.1016/j.surge.2017.06.001

DO - 10.1016/j.surge.2017.06.001

M3 - Review article

C2 - 28684167

AN - SCOPUS:85023743144

VL - 15

SP - 366

EP - 371

JO - The Surgeon

JF - The Surgeon

SN - 1479-666X

IS - 6

ER -